Article metrics

Download PDFPDF

The promise of combining CDK4/6 inhibition with hormonal therapy in the first-line treatment setting for metastatic or recurrent endometrial adenocarcinoma

 

Online download statistics by month:

Online download statistics by month: October 2023 to October 2024

AbstractFullPdf
Oct 202324206
Nov 2023698665129
Dec 2023635600135
Jan 202438237293
Feb 202420619369
Mar 2024293284104
Apr 202430429781
May 202421321380
Jun 202422220483
Jul 202425125054
Aug 202415213748
Sep 202418017262
Oct 202424024259
Total380036491003